Referral Prescription Capture Drives Significant 340B Savings Enhancing 340B’s Mission

SPONSORED CONTENT

OVERVIEW

Establishing a referral prescription capture program enables covered entities to broaden the reach of their 340B Drug Discount Program. Referral prescription capture can occur when patients of the covered entity utilize external specialists who are outside of the health system’s physician network.

Monitoring these opportunities not only increases the prescription volume that qualifies as 340B eligible, but the

Read More »

More Than 850 Hospitals Ask Feds to Appeal Judge’s 340B Contract Pharmacy Ruling

850+ hospitals in the 340B program sent the HHS secretary a letter yesterday asking the government to appeal a judge’s 340B contract pharmacy ruling.

Just over 850 hospitals in the 340B program asked the federal government yesterday to appeal a judge’s Nov. 5 ruling that halted enforcement actions against two drug companies that deny 340B pricing when hospitals and others use contract pharmacies. They

Read More »

Provider Groups Pan Lilly’s 340B Contract Pharmacy Policy Change

Groups representing health care providers have panned Lilly's recent 340B contract pharmacy policy change.

Groups representing 340B health centers, Ryan White clinics, and hospitals panned drug manufacturer Lilly’s recent decision to amend its prohibition on 340B pricing when providers use contract pharmacies to dispense drugs to patients.

Please Login or

Read More »

Is There a New 340B Stakeholder Group for Pharma Companies?

A new infographic by a drug industry consultant indicates it was created for the 340B Industry Roundtable—an apparently new 340B drug industry stakeholder group.

A new two-pager about the 340B program by drug industry consultant Berkeley Research Group (BRG) indicates it was created for the 340B Industry Roundtable—an apparently new 340B drug industry stakeholder group.

Please Login or Become a

Read More »

Democratic Defection on Build Back Better Act Sets Back Drive to Lower Drug Prices

U.S. Sen. Joe Manchin’s (D-W.Va.) rejection of his fellow Democrats’ Build Back Better (BBB) policy agenda left its drug pricing section dead in the water.

West Virginia U.S. Sen. Joe Manchin’s rejection Sunday of his fellow Democrats’ Build Back Better (BBB) policy agenda left its drug pricing section dead in the water.

Please Login or Become a Paid Subscriber to View

Read More »

Cloudmed Acquires 340B Technology Company par8o

par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has been acquired by Cloudmed.

Boston-based par8o, which provides 340B services including a platform to help 340B covered entities manage their patient referral claims, has been acquired by Cloudmed.

Please Login or Become a Paid Subscriber to View this Content

Read More »

HRSA Audits: Scared or Prepared?

SPONSORED CONTENT

Benjamin Franklin, an American Founding Father and Statesman, is attributed as being the source of the memorable quote “By failing to prepare, you are preparing to fail.” 

Today, compliance risk in the 340B Program remains significant for most covered entities.  The capabilities of many covered entities to reach all members of their communities with needed services and resources remains under intense pressure.  Hospitals, community

Read More »

In What Is Believed to Be the First State Action, W.Va. Says Express Scripts’ 340B Claims ID Policy Violates State Law

West Virginia Insurance Commissioner Allan McVey ruled that Express Scripts’ controversial 340B claims identification and submission requirement violates state law.

Pharmaceutical benefit manager Express Scripts’ (ESI) controversial 340B claims identification and submission requirement violates West Virginia law, state Insurance Commissioner Allan McVey has ruled.

Please Login or Become a Paid Subscriber to View this Content

Read More »

Senate Finance Committee’s New Drug Pricing Text Includes a New 340B Provision

The U.S. Senate Finance Committee’s latest drug pricing legislation includes 340B language not seen before in earlier House and Senate versions.

The U.S. Senate Finance Committee’s latest drug pricing legislation includes language, not seen before in earlier House and Senate versions, about denying 340B covered entities’ access to government-negotiated lower prices on drugs covered under Medicare.

Please

Read More »

Judge Grants Stay in Boehringer Ingelheim’s 340B Contract Pharmacy Lawsuit

A federal district judge has stayed Boehringer Ingelheim’s 340B contract pharmacy lawsuit.

A federal district judge in Washington, D.C., has paused Boehringer Ingelheim’s (BI) 340B contract pharmacy lawsuit while the federal government decides whether to appeal the same judge’s Nov. 5 joint ruling in Novartis and United Therapeutics’ (UT) contract pharmacy suits.

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
×

*Sign up for news summaries and alerts from 340B Report